Clinical trial
Use of a Novel, Objective Optokinetic Contrast Device to Determine Scotopic Range Visual Function and Discriminate Between Patients With and Without Glaucoma
NCT02014597 is registered in ClinicalTrials.gov with Benjamin Frankfort, MD, PhD as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Use of a Novel, Objective Optokinetic Contrast Device to Determine Scotopic Range Visual Function and Discriminate Between Patients With and Without Glaucoma
- Lead sponsor
- Benjamin Frankfort, MD, PhD
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- May 31, 2015
- Completion date
- August 22, 2017
- Enrollment
- 23 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.